IRONWOOD PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IRONWOOD PHARMACEUTICALS INC DBCV 2.250% 6/1, CUSIP 46333XAD0.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IRONWOOD PHARMACEUTICALS INC DBCV 2.250% 6/1, CUSIP 46333XAD0.